These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8689630)
1. Cationic liposomes enhance retrovirus-mediated multinucleated cell formation and retroviral transduction. Kaneko Y; Tsukamoto A Cancer Lett; 1996 Jul; 105(1):39-44. PubMed ID: 8689630 [TBL] [Abstract][Full Text] [Related]
2. Gene therapy of hepatoma: bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovir. Kaneko Y; Tsukamoto A Cancer Lett; 1995 Sep; 96(1):105-10. PubMed ID: 7553597 [TBL] [Abstract][Full Text] [Related]
3. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
4. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo. Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181 [TBL] [Abstract][Full Text] [Related]
5. Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir. Yang L; Hwang R; Pandit L; Gordon EM; Anderson WF; Parekh D Ann Surg; 1996 Sep; 224(3):405-14; discussion 414-7. PubMed ID: 8813269 [TBL] [Abstract][Full Text] [Related]
6. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm. Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908 [TBL] [Abstract][Full Text] [Related]
8. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene. Benedetti S; Dimeco F; Pollo B; Cirenei N; Colombo BM; Bruzzone MG; Cattaneo E; Vescovi A; Didonato S; Colombo MP; Finocchiaro G Hum Gene Ther; 1997 Jul; 8(11):1345-53. PubMed ID: 9295129 [TBL] [Abstract][Full Text] [Related]
9. Ablation of tumor cells in vivo by direct injection of HSV-thymidine kinase retroviral vector and ganciclovir therapy. Howard BD; Kalthoff H; Fong TC Ann N Y Acad Sci; 1999 Jun; 880():352-65. PubMed ID: 10415879 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene. Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543 [TBL] [Abstract][Full Text] [Related]
11. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer. Tang Q; Zhang D; Wan M; Jin L Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766 [TBL] [Abstract][Full Text] [Related]
12. Retrovirus-mediated suicide gene transduction in the vitreous cavity of the eye: feasibility in prevention of proliferative vitreoretinopathy. Kimura H; Sakamoto T; Cardillo JA; Spee C; Hinton DR; Gordon EM; Anderson WF; Ryan SJ Hum Gene Ther; 1996 May; 7(7):799-808. PubMed ID: 8860832 [TBL] [Abstract][Full Text] [Related]
13. Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy. Hasegawa Y; Nishiyama Y; Imaizumi K; Ono N; Kinoshita T; Hatano S; Saito H; Shimokata K Cancer Gene Ther; 2000 Apr; 7(4):557-62. PubMed ID: 10811473 [TBL] [Abstract][Full Text] [Related]
14. HSV-tk gene therapy for human renal cell carcinoma in nude mice. Pulkkanen KJ; Parkkinen JJ; Laukkanen JM; Kettunen MI; Tyynela K; Kauppinen RA; Ala-Opas MY; Yla-Herttuala S Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775 [TBL] [Abstract][Full Text] [Related]
15. Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors. Kruse CA; Roper MD; Kleinschmidt-DeMasters BK; Banuelos SJ; Smiley WR; Robbins JM; Burrows FJ Cancer Gene Ther; 1997; 4(2):118-28. PubMed ID: 9080121 [TBL] [Abstract][Full Text] [Related]
17. Limitations of retrovirus-mediated HSV-tk gene transfer to pulmonary adenocarcinoma cells in vitro and in vivo. Zhang L; Wikenheiser KA; Whitsett JA Hum Gene Ther; 1997 Mar; 8(5):563-74. PubMed ID: 9095408 [TBL] [Abstract][Full Text] [Related]
18. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Oldfield EH; Ram Z; Culver KW; Blaese RM; DeVroom HL; Anderson WF Hum Gene Ther; 1993 Feb; 4(1):39-69. PubMed ID: 8384892 [TBL] [Abstract][Full Text] [Related]
19. Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model. Vlachaki MT; Chhikara M; Aguilar L; Zhu X; Chiu KJ; Woo S; Teh BS; Thompson TC; Butler EB; Aguilar-Cordova E Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1008-17. PubMed ID: 11704325 [TBL] [Abstract][Full Text] [Related]
20. Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene. Carrió M; Romagosa A; Mercadé E; Mazo A; Nadal M; Gómez-Foix AM; Fillat C Gene Ther; 1999 Apr; 6(4):547-53. PubMed ID: 10476214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]